Thierry Hercend

Venture Partner, Life Sciences Team at Andera Partners

Thierry is currently Chairman of the board of Inotrem and GamaMabs and he is a member of the board of Poxel, Grey Wolf Therapeutics and Complix. He was also a board member of U3 Pharma and PegaOne, and Chairman of the board of Oncoethix until their acquisition by large pharmaceutical companies.

Org chart

Manager

Stéphane Bergez

Head & Partner

Peers

Antoine Le Bourgeois

Partner, Midcap Team

Arthur Milliard

Investment Director, Midcap Team

Vincent Bazzocchi

Investment Director, Midcap Team

Teams

+27

Leadership Team

30 members

Timeline

Venture Partner, Life Sciences Team
January, 2006 - present

View in org chart